Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Landegren Gene Technology AB
AB
Active
Org 5567052302
Norra Parkvägen 29, 756 45
Uppsala
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2006
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Landegren Gene Technology AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2021
-1M
2022
-1M
2023
0M
2024
-1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
−1
Staff expenses
—
—
—
—
—
EBITDA
−503
−530
−648
−402
−634
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
−503
−530
−648
−402
−634
Net financials
45 176
−23 166
70 962
17 661
724 951
Profit before tax
44 673
3 759
70 315
17 837
724 317
Tax
−2 677
−69
−1 476
1 040
−1 639
Net profit
41 996
3 690
68 839
18 877
722 678
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
727 773
699 192
749 410
767 685
1 491 430
Equity
628 269
631 959
700 798
719 675
1 442 353
Long-term debt
96 612
43 128
47 846
47 922
47 999
Short-term debt
2 892
24 105
766
88
1 078
Total debt
99 504
67 233
48 612
48 010
49 077
Financial ratios
5-year trend
EBITDA margin
-63400000.0%
This company
15.8%
Market median
-401265923% vs market
2021
2025
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
2021
2025
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
2021
2025
Net profit margin
72267800000.0%
This company
8.1%
Market median
+892195061628% vs market
2021
2025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Landegren Gene Technology AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
